Siteman Cancer Center
Vignettes of Research
The Siteman Cancer Center is the world’s leading center for cancer genomics having sequenced the first cancer genome in the world in 2008 – which was essentially the start of personalized medicine. Right now – Siteman is conducting a number of exciting research investigations – including Graft vs Host Disease (GvHD), looking at Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) and its molecular underpinnings, novel immunotherapies for Acute Leukemia and Myeloma, and novel cellular therapies for hematologic malignancies.
The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Missouri, USA – is the only cancer center in Missouri to hold the prestigious Comprehensive Cancer Center designation and “Exceptional” rating from the National Cancer Institute and membership in the National Comprehensive Cancer Network. Siteman offers the expertise of more than 450 Washington University research scientists and physicians who provide care for nearly 10,000 newly diagnosed cancer patients each year. The results of basic laboratory research are rapidly incorporated into treatment advances, which is enhanced by patient access to more than 500 therapeutic clinical trials, including many collaborative efforts with other leading cancer centers throughout the country.
Parent institutions Barnes-Jewish Hospital and Washington University School of Medicine are nationally recognized, with U.S. News & World Report magazine consistently ranking both among the best in the United States.